Plasma Market Dynamics & COVID19 Impact
How has the industry responded to the pandemic challenge?
• Due to the challenge created by COVID-19 to the plasma supply, companies in the United States
have responded aggressively to increase collections
•
Over 100 new plasma collection centers gained FDA licenses in 2020, and almost 110 more in 2021
By end of 2021, nearly 1050 FDA licensed centers in US, up 24% from 2 years earlier
• Donor fees were raised significantly, offering up to $1100-$1200 for 8 donations in first month.
• Average donor fees went from under $60 a donation pre-pandemic to around $80 a donation in 2021
• At the same time, Europe has also made some moves to increase the regional plasma supply:
•
•
•
The United Kingdom has begun to use plasma (including source) for fractionation
Poland has acquired thousands of plasmapheresis machines, hoping to double or triple its volume of
plasma for fractionation
Several countries have launched new programs to collect more source plasma
Private companies in Germany, Austria, Czech Republic and Hungary continue to add more plasma
collection centers
13
(MRBView entire presentation